Top Anti Cancer Imported Medicine Drugs in India - Pharama Five
Help Desk :+916374297988

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org

Best Libtayo (Cemiplimab) Medicine in India

Buy Libtayo (Cemiplimab) Medicine in India

Libtayo (Cemiplimab)

Medicine name : Libtayo

Generic name : Cemiplimab

Manufactured By : Regeneron

Indications : NSCLC With High PD-L1

Medicine Description : Libtayo is a PD-1 checkpoint inhibitor for cutaneous squamous cell carcinoma (CSCC), NSCLC, and basal cell carcinoma (BCC). It boosts the immune system’s attack on cancer. Given via IV infusion, it offers durable responses. Side effects include immune-related colitis, pneumonitis, and liver inflammation. Close immune toxicity monitoring is essential.

Product Introduction

Libtayo (Cemiplimab) is an immunotherapy medicine used to treat certain types of advanced cancers, including cutaneous squamous cell carcinoma (CSCC), basal cell carcinoma (BCC), and certain non-small cell lung cancers (NSCLC), depending on the patient's condition and treatment plan. It is a monoclonal antibody that helps the immune system recognize and attack cancer cells by blocking the PD-1 pathway.

Libtayo (Cemiplimab) is administered by a healthcare professional through an intravenous infusion. The dose and treatment schedule are determined by your doctor based on your type of cancer, overall health, and response to treatment. Regular medical check-ups and laboratory tests may be required to monitor your response and detect immune-related side effects.

Common side effects of Libtayo may include fatigue, rash, diarrhea, itching, decreased appetite, nausea, constipation, cough, and muscle or joint pain. Because it activates the immune system, it can also cause inflammation affecting organs such as the lungs, liver, intestines, kidneys, thyroid, or other organs. Inform your doctor promptly if you develop severe diarrhea, breathing difficulties, yellowing of the skin or eyes, changes in urination, severe rash, or other unusual symptoms.

Uses Of Libtayo (Cemiplimab)

Treatment of Advanced Skin and Lung Cancers

Benefits Of Libtayo

Libtayo (Cemiplimab) is an immunotherapy medicine used to treat certain advanced cancers, including cutaneous squamous cell carcinoma (CSCC), basal cell carcinoma (BCC), and certain non-small cell lung cancers (NSCLC), depending on the patient's condition and treatment plan. It blocks the PD-1 pathway, helping the immune system recognize and attack cancer cells. This can help reduce cancer growth, slow disease progression, and provide better control of advanced cancer in eligible patients.

Side Effects Of Libtayo (Cemiplimab)

Some side effects of Libtayo (Cemiplimab) may improve as your body adjusts to the medicine. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Libtayo (Cemiplimab)

  • Fatigue
  • Rash
  • Diarrhea
  • Itching
  • Decreased appetite
  • Nausea
  • Constipation
  • Cough
  • Muscle pain
  • Joint pain
How To Use Libtayo

Libtayo (Cemiplimab) is administered by a healthcare professional through an intravenous infusion. The dose and treatment schedule are determined by your doctor based on your type of cancer, overall health, and response to treatment. Do not change or stop treatment without your doctor's advice. Regular medical check-ups and blood tests may be required during treatment.

How Libtayo (Cemiplimab) Works

Libtayo (Cemiplimab) is an immunotherapy medicine that blocks a protein called PD-1 on immune cells. Cancer cells can use the PD-1 pathway to avoid being attacked by the immune system. By blocking this pathway, Cemiplimab helps activate the immune response so immune cells can better recognize and destroy cancer cells. This helps slow cancer growth and progression in eligible patients.

Safety Advice

AlcoholCONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol during treatment with Libtayo (Cemiplimab).

PregnancyCONSULT YOUR DOCTOR

Libtayo (Cemiplimab) may harm an unborn baby. Inform your doctor if you are pregnant or planning to become pregnant. Use effective contraception as advised by your doctor.

BreastfeedingCONSULT YOUR DOCTOR

Do not breastfeed during treatment with Libtayo (Cemiplimab). Consult your doctor for guidance.

DrivingCONSULT YOUR DOCTOR

Libtayo may cause fatigue, dizziness, or other effects that can affect your ability to drive safely. Avoid driving if these symptoms occur.

KidneyCAUTION

Inform your doctor if you have kidney problems before starting treatment. Your doctor may monitor kidney function during therapy.

LiverCAUTION

Tell your doctor if you have liver problems. Libtayo can cause immune-related liver inflammation, so your doctor may monitor liver function regularly.

Quick Tips
  • Attend all scheduled Libtayo (Cemiplimab) infusions and follow your doctor's treatment schedule carefully.
  • Report diarrhea, abdominal pain, or changes in bowel habits promptly, as these may indicate immune-related inflammation.
  • Contact your doctor immediately if you develop new or worsening cough, breathing difficulties, or chest pain.
  • Report yellowing of the skin or eyes, dark urine, severe fatigue, changes in urination, or significant swelling promptly.
  • Attend regular blood tests and medical check-ups to monitor your liver, kidney, thyroid, and other organ functions during treatment.
  • Read More About - Libtayo (Cemiplimab) from Pharma Five.
Faq

General Question

Libtayo (Cemiplimab) is a prescription drug used to treat certain types of cancer, including advanced cutaneous squamous cell carcinoma (CSCC), non-small cell lung cancer (NSCLC), and basal cell carcinoma (BCC).

Libtayo is an immune checkpoint inhibitor that blocks the PD-1 protein, helping the immune system recognize and attack cancer cells.

Doctors prescribe Libtayo for adults with advanced CSCC, NSCLC with high PD-L1 expression, or BCC that has spread or cannot be treated with surgery or radiation.

Libtayo is given as an intravenous (IV) infusion, usually once every three weeks, under medical supervision.

Common side effects of Libtayo include fatigue, rash, diarrhea, nausea, muscle pain, and cough.

Yes, Libtayo may cause immune-related side effects, such as inflammation of the lungs, liver, intestines, or thyroid. Seek medical attention if you experience severe symptoms.

Libtayo is usually taken as long as it remains effective and well-tolerated, or until your doctor decides to stop the treatment.

It is best to avoid alcohol while taking Libtayo, as it may increase the risk of liver problems and worsen side effects.

No, Libtayo may harm an unborn baby. Women should use effective contraception while receiving this treatment.

Yes, Libtayo may interact with other drugs, especially those that affect the immune system. Inform your doctor about all medications you take.

If you miss a Libtayo infusion appointment, contact your doctor immediately to reschedule your treatment.

Libtayo is an IV infusion and is not taken orally, so food intake does not affect its administration.

Monitor for signs of immune-related side effects, avoid live vaccines, and inform your doctor of any existing health conditions before starting treatment.

Libtayo is stored and handled by healthcare professionals and should be kept in a controlled medical environment.

Libtayo is available by prescription and is administered in hospitals or cancer treatment centers. Consult your doctor for access to this medication. Pharma Five assists in its procurement.